Navigation Links
ShangPharma Announces Third Quarter 2012 Results
Date:11/20/2012

s

7

-  Property, plant, equipment and software, net

86,521

89,498  Land use right, net

6,634

6,487  Other long-term assets

559

663  Amounts due from related parties

225

224  Deferred tax assets

609

659Total non-current assets94,55597,531Total assets166,903169,830LIABILITIESCurrent liabilities:  Accounts payable

16,307

15,486  Amounts due to related parties

123

1,381  Salary and welfare payable

3,864

2,865  Income tax payable

3,241

1,407  Advance from customers

1,596

726  Other payables and accruals

5,613

4,146Total current liabilities30,74426,011Non-current liabilities:  Advanced subsidies3,121

4,077Total non-current liabilities3,1214,077Total liabilities33,86530,088Commitments and contingenciesEQUITYOrdinary shares (US$0.001 par value; 500,000,000 shares authorized; 336,109,400 and 337,973,959 shares issued and outstanding as of December 31, 2011 and September 30, 2012, respectively)

336

336Additional paid in capital

84,924

89,183Statutory reserves

8,552

8,552Retained earnings

33,013

36,723Accumulated other comprehensive income

7,305

6,639Less: Treasury stock, at cost; 2,237,148 and 3,681,666 shares as of
December 31, 2011 and September 30, 2012, respectively

(1,092)

(1,691)Total equity133,038139,742Total liabilities and equity166,903169,830 

SHANGPHARMA CORPORATIONUNAUDITED CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (in thousands of U.S. dollars, except for ADS(1) data and per ADS data)

Three months ended

Nine months endedSeptember 30,

Sep
'/>"/>

SOURCE ShangPharma Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. ShangPharma to Report Third Quarter 2012 Financial Results on November 20, 2012
2. ShangPharma and Harbour Antibodies Announce Licensing Agreement
3. ShangPharma Announces Second Quarter 2012 Results
4. ShangPharma to Report Second Quarter 2012 Financial Results on August 20, 2012
5. ShangPharma Independent Committee Appoints Financial Advisor
6. ShangPharma Independent Committee Appoints Chairman and Legal Counsel
7. ShangPharma Announces Receipt of "Going Private" Proposal at $8.50 to $9.50 Per ADS
8. ShangPharma Announces First Quarter 2012 Results
9. ShangPharma to Report First Quarter 2012 Financial Results on May 17, 2012
10. ShangPharma Corporation Files 2011 Annual Report on Form 20-F
11. Dr. TATTOFF Announces Use of Astanza Laser Tattoo Removal Systems for New Phoenix Location
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... Massachusetts y LONDRES, August 30, 2015 /PRNewswire/ ... ofrece una visión holística de l ... todo el trayecto   ... hoy el debut europeo de IntelliSpace Cardiovascular , ... que ofrece sofisticadas herramientas para acceder, analizar y compartir ...
(Date:8/28/2015)... , Aug. 28, 2015  Delays in ... projects can slow down the decision-making process, resulting ... therefore, absolutely critical for biopharmaceutical companies to develop ... approval process for quicker and more meaningful insights. ... Best Practices, LLC, nearly three-quarters of benchmarked study ...
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... their offering. Originally discovered by Welfide ... Pharmaceutical Industries, Ltd) as an inflammatory drug, pranoprofen ... Pharmaceutical Co., Ltd under the trade name of ...
Breaking Medicine Technology:Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3Expediting the Pharmaceutical Market Research Process for Faster Insights 2Investigation Report on China's Pranoprofen Market, 2010-2019 2
(Date:8/31/2015)... ... August 31, 2015 , ... ... was formed in 2008, the result of a merger of five of the ... working cooperatively, they could provide more cost-effective and higher quality care than they ...
(Date:8/31/2015)... Scotch Plains, NJ (PRWEB) , ... August 31, 2015 , ... NJ Top Docs Presents, ... Doc”!, Born and raised in Park Ridge, New Jersey, Dr. Michael Betsy graduated from Don ... and ice hockey and served as team captain in both sports in his senior year. ...
(Date:8/31/2015)... ... , ... Dr. Stewart Shofner of Shofner Vision Center explains what ... a comprehensive eye examination can diagnose amblyopia. According to the National Eye Institute ... approximately 2 to 3 out of every 100 children. , Dr. Shofner adds, ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... communications company announced today that it has officially launched a new website and ... website and brand refresh are more closely aligned with the company’s strategic vision ...
(Date:8/31/2015)... ... ... Three Bakers Gluten Free Bakery launched the redesign of its website, ... on their offering of gluten-free breads and pizzas, living without gluten, and resources for ... to share information about our gluten free product offerings, but also to really be ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Garden State Urology! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Three Bakers Gluten Free Bakery Announces Launch of New Website 2
... Locoid Lotion was recently introduced at the ... Chicago, Illinois, for the treatment of mild-to-moderate ... Triax Pharmaceuticals, LLC, the marketers of Locoid ... brand in corticosteroids, recently launched the new ...
... 12, 2008 (Portland, Ore.) People who lose weight ... control of their blood pressure and blood sugar, and are ... their weight, according to a Kaiser Permanente study published online ... , This is the first clinical study to ...
... to the Head of the Class, WASHINGTON, Aug. ... heading back to classrooms this month, and 8,million (16%) ... according to the Asthma and Allergy Foundation of America,s,(AAFA) ... Asthma and,Allergy Policies for Schools -- many schools are ...
... MEDRAD, INC., announced today,that the wireless version ... Food and Drug Administration (FDA) 510(k) clearance., ... Continuum Wireless MR Infusion System enables the clinician ... resonance (MR),procedure from both inside and outside the ...
... ETHEX Corporation Subsidiary ... of October 24, 2008 for Gestiva(TM), ST. LOUIS, Aug. 11 KV Pharmaceutical Company,(NYSE: KVa/KVb) ... Fiscal 2009 First Quarter Financial Highlights (Unaudited), USD in millions ... Change ...
... Celsius Holdings,Inc. (OTC Bulletin Board: CSUH.OB) reported net sales ... $1.0 million -- a substantial increase,as compared to $376,000 for ... reported a net loss of $916,000 (or $0.01 per basic ... This compares,with net loss of $726,000 (or $0.01 per basic ...
Cached Medicine News:Health News:Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1% 2Health News:Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1% 3Health News:Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1% 4Health News:Losing weight soon after type 2 diabetes diagnosis doubles positive outcomes 2Health News:Six States Named to National Asthma & Allergy Honor Roll 2Health News:Six States Named to National Asthma & Allergy Honor Roll 3Health News:MEDRAD Receives FDA 510(k) Clearance for Wireless MR Infusion System 2Health News:MEDRAD Receives FDA 510(k) Clearance for Wireless MR Infusion System 3Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 2Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 3Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 4Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 5Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 6Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 7Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 8Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 9Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 10Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 11Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 12Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 13Health News:KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results 14Health News:Celsius Holdings Reports Increased Revenue 2nd Quarter Revenue Increased 166% 2Health News:Celsius Holdings Reports Increased Revenue 2nd Quarter Revenue Increased 166% 3Health News:Celsius Holdings Reports Increased Revenue 2nd Quarter Revenue Increased 166% 4Health News:Celsius Holdings Reports Increased Revenue 2nd Quarter Revenue Increased 166% 5
The Plasma Extractor is used to express blood components from collection containers. The spring-loaded front panel exerts pressure on the collection container causing the fluid to transfer until cont...
The Eppendorf Maxipettor is a continuously adjustable pipette for precise pipetting of volumes up to 10 ml (in 10 l increments). Even liquids with a high vapor pressure or viscosity can be pipetted w...
... only catheter of its kind, the ... collects real-time cardiac electrical information, translating ... With 64 electrodes, this unique tool ... than 3,000 points of electrical data ...
... The St. Jude Medical® Pacing System Analyzer ... solution for implantation testing, programming and interrogation ... as an easy-to-use accessory to the St. ... testing by obtaining measurements of intrinsic P- ...
Medicine Products: